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A B S T R A C T
Many assays for detection of antibodies against porcine epidemic diarrhea virus (PEDV) are based on detection of
neutralizing antibodies or immunoglobulin (Ig) G in serum samples. However, due to the particular features of
the mucosal immune system, presence of serum antibodies against enteric pathogens, such as PEDV, not always
correlates with protection. In contrast, anti-PEDV IgA antibodies correlate with protection against subsequent
challenges. An indirect PEDV IgA ELISA was previously developed to monitor IgA levels in colostrum and milk
samples. In the present paper we describe an adaptation of the protocol for detection of IgA antibodies in serum
and fecal samples.
! The adapted protocol will aid in future assessment of protective levels of humoral response against PEDV
infection by measuring IgA levels in serum and fecal samples.
! Fecal samples are non-invasive and easy to collect at any time by animal caretakers and therefore offering
advantages over the serum sample collection procedure.
* Corresponding author [5_TD$DIFF]at: The Roslin Institute and The Royal (Dick) School of Veterinary Studies, University of EdinburghQ2 ,
Midlothian, UK.
E-mail address: tanja.opriessnig@roslin.ed.ac.uk (T. Opriessnig).
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9
10 Method details
11 The present study was designed to adapt an indirect ELISA protocol for the detection of anti-
12 porcine epidemic diarrhea virus (PEDV) IgA in serum and feces samples to compare the capability of
13 detection of IgA in the two differentmatrix types. The spike gene S1 domain (aa 1–781) of a genogroup
14 2 prototype U.S. PEDV expressed in a mammalian vector was used as antigen [1].
15 Control samples
16 Fecal and serum controls for the IgA PEDV S1-ELISA were obtained from a pig infected
17 experimentally with PEDV (positive control) or from a pig sham-infected (negative control) at 28 days
18 post infection or sham infection (dpi) [2,3]. The experimental protocol was approved by the Iowa State
19 University Institutional Animal Care andUse Committee (Approval No. 2-14-7742-S). In brief, 3-week-
20 old PEDV negative pigs were inoculated with 10ml of the 5[9_TD$DIFF]th passage of PEDV isolate 13-19338E at a
21 tissue culture infective dose (TCID50) of 5"102 perml via the oral route or sham-inoculatedwith 10ml
22 of virus negative culture medium via the oral route. Rectal swabs were collected at 0, 1, 3 and 7dpi.
23 Serum samples were collected at 0, 7, 14, 21 and 28dpi, fecal samples were collected at 28dpi, and the
24 samples were aliquoted in 1.5ml microcentrifuge tubes and stored at [10_TD$DIFF]#808C until use. The pigs were
25 humanely euthanized and necropsied at 28dpi. Presence or absence of PEDV infectionwere confirmed
26 by RT-PCR on rectal swabs [2,3] and by an IgG immunofluorescence assay (IFA) in serum samples as
27 routinely performed at the Iowa State University Veterinary Diagnostic Lab (ISU-VDL).
28 Buffers
2931 [11_TD$DIFF]Coating buffer. 50mM carbonate buffer, pH9.6
32 [12_TD$DIFF]Blocking buffer. Phosphate buffered saline (PBS) pH 7.2 containing 0.05% Tween 20 (PBST), 1%
33 bovine serum albumin, 10% sucrose (Gibco, Life Technologies)
34 [13_TD$DIFF]Assay diluent. PBST 10% goat serum (Gibco, Life Technologies)
35 [14_TD$DIFF]Washing buffer. PBST
36 Plate coating and blocking
379 1.40 Microtiter plates (Maxisorp, Nunc) were coated with 0.44ng per well (100ml) of the S1 antigen
41 diluted in coating buffer and incubated overnight at 4 8C.
42 2.3 After three washes with washing buffer, the plates were incubated with blocking buffer for 2h at
44 228C. Plates were used immediately after blocking or dried at 378C for [15_TD$DIFF]2–4h and stored at 48C until
45 use.
46 Preparation of samples
479 [16_TD$DIFF] ecal samples. Fresh fecal samples and controls were diluted at 1:10 w/v (0.1g in 0.9ml) with assay
50 diluent, thoroughly homogenized by vortexing for 30s [17_TD$DIFF]and centrifuged at 4000"g for 10min.
! A strong positive correlation between the anti-PEDV levels in fecal and serum samples was identified;
however, detection of IgA antibodies was often more successful in serum than in paired fecal samples due to
overall lower sample-to-positive (S/P) ratios for the latter sample type.
! 2015 Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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51 [18_TD$DIFF]Serum samples. Serum samples and controls were diluted at 1:100 (3ml in 300ml) with assay
52 diluent. Samples were mixed thoroughly before being distributed on the plates.
53 [19_TD$DIFF]ELISA procedure
54 Primary antibody incubation
55
57 [16_TD$DIFF] ecal samples. Clarified diluted fecal samples or controls were added to each well and incubated at
58 48C for [20_TD$DIFF]16–18h. After incubation, plates were washed 3 times with washing buffer.
59 [18_TD$DIFF]Serum samples. Diluted samples or controls (100ml) were added to eachwell and incubated at 37 8C
60 for 1h. Controls were tested in duplicate. After incubation, plates were washed 3 times with
61 washing buffer.
62 [21_TD$DIFF]Secondary antibody incubation
63
65 a.6 Anti-porcine IgA antibodies (Goat anti-swine IgAHRP-conjugated, Bethyl) were diluted at 1:5000 in
67 assay diluent
68 b.9 The secondary antibody (100ml) was added to each well and incubate at 378C for 30min.
70 c.1 After incubation, plates were washed 3 times with washing buffer.
72 Third incubation using substrate
73
75 a.6 TMB substrate (100ml; SureBlueTM TMBMicrowell Peroxidase Substrate Kit, KPL Inc.) was added to
77 each well and incubated at 22 8C for 20min in the dark.
78 b.9 The reaction was stopped by addition of 50ml of 2M sulphuric acid solution per well.
80 c.1 Absorbance of the samples and controls was read at 450nm (ELx808 Absorbance Microplate
82 Reader; BioTek).
83 Test interpretation
84 A run on a particular plate was considered to be valid when the negative control optical density
85 (OD) was lower than 0.15 and the positive control OD value was higher than 0.60. The S/P ratio was
86 calculated using the following formula: S/P ratio=[(Sample OD [22_TD$DIFF]#Negative sample OD)/(Positive
87 sample OD [23_TD$DIFF]#Negative sample OD)].
88 For the IgA ELISA on fecal samples an S/P ratio less than 0.13 was considered negative and an S/P
89 ratio higher or equal to 0.13was considered positive. For serum samples an S/P ratio less than 0.14was
90 considered negative and an S/P ratio higher or equal to 0.14 was considered positive.
91 Method validation
92 For the optimization of the assay, a total of 69 paired serum and fecal samples from pigs with
93 known PEDV exposure [2,3] were used. Source of the pigs and inoculation were similar to what has
94 been described under ‘‘control samples’’. Specifically samples collected at 28dpi from 31 PEDV
95 infected pigs and 38 sham inoculated negative control pigs were utilized [2,3]. Samples were
96 tested in single wells in at least two independent runs and the mean S/P value was used for each
97 sample.
98 The cut off value for the IgA ELISA was calculated by the mean S/P ratios of PEDV negative samples
99 plus three standard deviations (SD). The cut off points were determined to be a sample S/P ratio of 0.13
100 (average S/P$SD, 0.02$0.03) for the fecal ELISA and sample S/P ratio of 0.14 (average S/P$SD,
101 0.00$0.01) for the serum ELISA. These values were further evaluated using a receiver operator
102 characteristic (ROC) analysis (Fig[1_TD$DIFF]. 1). The analysis was performed using GraphPad Prism v. 6.01 (GraphPad
103 Software, La Jolla, CA, USA).
104 A correlation between S/P values in serum and the corresponding fecal sample from a given pigwas
105 determined using Spearman’s rank correlation method. A significant positive correlation was found
106 between fecal and serum anti-IgA levels (r=0.7889; p<0.001, Fig. 2).
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[(Fig._1)TD$FIG]
Fig [1_TD$DIFF]. 1.Distribution of anti-IgA porcine epidemic diarrhea virus (PEDV) ELISA sample to positive (S/P) ratios on (A) serum and (B)
fecal samples distributed according to PEDV challenge status of the animal (no, yes) relative to the assay cut off (full line). An S/P
ratio higher or equal to 0.14 was considered positive for serum samples and an S/P ratio higher or equal to 0.13 was considered
positive for fecal samples.
[(Fig._2)TD$FIG]
Fig [1_TD$DIFF]. 2. Correlation of anti-IgA porcine epidemic diarrhea virus (PEDV) sample to positive (S/P) ratios on paired serum and fecal
samples.
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107 Background
108 PEDV, a member of the genus Alphacoronavirus in the family Coronaviridae, causes acute diarrhea,
109 vomiting, dehydration in pigs of any age with often high mortality in neonatal piglets. PEDV strains
110 can be divided into genogroup 1 and genogroup 2 based on significant amino acid differences in the N-
111 terminal domain of the S gene [4]. PEDV infection has resulted in high economic losses in Asian pig
112 industries, the disease has been reported in 2013 in North America and in 2014 in South America [5]
113 and recent outbreaks have been described in Europe during 2015. Most PEDV strains circulating in
114 Europe and in Asia prior to 2010 belong to genogroup 1 while the more recent outbreaks were
115 associated with PEDV genogroup 2. PEDV genogroup 2 can be divided in at least two major clusters,
116 one containing the strains similar to the ones that emerged in the US in 2013 (U.S. PEDV prototype
117 strain) and the other cluster containing PEDV strainswith distinct insertions and deletions in the spike
118 gene (S INDEL strains) [6]. Although the antigen used for the ELISA development in the present study
119 was based on the U.S. PEDV prototype strain, the same protocol can be applied for S1 antigens based on
120 different strain sequences that may be more relevant in a certain geographic location.
121 Due to the similarities in clinical signs with other enteric pathogens and as part of eradication
122 attempts, accurate and timely diagnosis of PEDV infection is important. A number of commercial and
123 in-house PEDV ELISA techniques have been developed for detection of antigen in feces or antibodies in
124 serum and colostrum [1,7–14].
125 Due to the particular features of the mucosal immune system, the presence of serum antibodies
126 against pathogens that replicate primarily inmucosal surfaces, such as PEDV and other coronaviruses,
127 is not always correlated with protection; rather, detection of these antibodies only indicates that
128 individuals had previous contact with infectious microorganisms [15–17] or were vaccinated.
129 Therefore, for mucosal infections, measurement of localized IgA immune responses is critical to
130 evaluate protection derived either by vaccines or by previous pathogen exposure. Indeed, a previous
131 study has shown that anti-PEDV IgA antibodies in serum samples correlated with protection against a
132 subsequent challenge 21 days after the first inoculation [18]. In veterinary diagnostics, serum is a
133 standard sample for serological testing; however, in case of enteric pathogens, testing fecal samples
134 perhaps would allow a better assessment of local immunity.
135 Fecal samples have many advantages over serum samples including ease of collection by animal
136 caretakers, a non-invasive collection procedure, and collection of samples on an as-needed basis.
137 Drawbacks include the presence of inhibitors and a lower concentration of analytes. A good
138 correlation was found between the levels of PEDV IgA antibodies in serum and fecal samples
139 indicating that either fecal material or serum could be used for assessing local PEDV immunity in pig
140 herds. Future studies should also assess oral fluids for suitability as a sample type to assess herd
141 immunity. However, similar to fecal samples, inhibitors and low analyte concentrations may impair
142 detection of antibodies in this sample type [19]. In addition, pen-based oral fluid samples represent
143 composite samples from 25 up to 350 pigs and establishing the rates of individual protection appears
144 not feasible.
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